Clinical Research Directory
Browse clinical research sites, groups, and studies.
PANDIA IRIS: Patients With Diabetes and Kidney Failure, an Interdisciplinary Medication Adherence Support Program
Sponsor: Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
Summary
Monocentric, randomised, controlled and open study. Subjects will be included prospectively and consecutively and randomly assigned into two groups. Intervention group A will benefit a medication adherence support program during 12 months while intervention group B during 6 months only. Adherence will be monitored using an Electronic Monitoring system (EM, named MEMS®; Aardex Ltd.) during 24 months. At each pharmacy visit, the pharmacist will conduct a semi-structured interview in 15 minutes based on Fisher's sociocognitive model with the patients. A summary of the interview and the adherence graph will be send to the patient' health professionals.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
73
Start Date
2016-04-14
Completion Date
2022-12-20
Last Updated
2026-07-17
Healthy Volunteers
No
Interventions
Inteprofessional medication adherence support program (IMAP)
In addition to usual care, patients participate in a medication adherence support program combining an Electronic Monitoring system (EM, named MEMS®; Aardex Ltd) and motivational semi-structured interviews. This programm is done by the Unisanté's community pharmacists, in coordination with medical and nurse staff , to support medication adherence and to promote continuity of care. The intervention is held at the Unisanté's community pharmacy. For patients not speaking french, english, or italien, the interviews will be done with a interpreter.
Locations (2)
Centre Hospitalier Universitaire Vaudois
Lausanne, Canton of Vaud, Switzerland
Unisante
Lausanne, Canton of Vaud, Switzerland